Clinical trial
Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU, A Randomized Controlled Study.
NCT02122055 is registered in ClinicalTrials.gov with Tianjin Third Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU, A Randomized Controlled Study.
- Lead sponsor
- Tianjin Third Central Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2014
- Completion date
- April 30, 2015
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
mechanical ventilation complication